Literature DB >> 8444240

Problems with the biochemical diagnosis in mitochondrial (encephalo-)myopathies.

J M Trijbels1, H R Scholte, W Ruitenbeek, R C Sengers, A J Janssen, H F Busch.   

Abstract

Patients suffering from a mitochondrial (encephalo-)myopathy have a remarkable clinical heterogeneity. A reliable and extensive investigation must be performed in order to obtain a correct diagnosis, but many factors may influence the ultimate results of these investigations leading, under certain circumstances, to an incorrect diagnosis. Patients selection is of crucial importance. Metabolic examination of body fluids, particularly with respect to lactate accumulation, is used as a selection criterion for further examinations. Numerous aspects associated with this metabolic examination have been critically evaluated, including the phenomenon of other causes of lactic acidaemia apart from mitochondrial disorders. Correct performance of in vivo function tests may contribute to a reduction of the number of missed diagnoses. Selection of the controls for biochemical investigations must be accurately be performed to obtain reliable reference values. Knowledge of the age-dependency of the biochemical parameters is necessary for a correct interpretation. It goes without saying that the choice of the tissue for biochemical investigations is of utmost importance. Knowledge of the tissue-specific occurrence of some defects in the mitochondrial respiratory chain is necessary. The biochemical examinations can be performed both in biopsy and autopsy material but only under certain conditions. Diagnostic approach requires application of reliable biochemical methods which are described. One of the most intriguing aspects in the diagnosis of mitochondrial disorders is the significance of a defect in relation to the residual enzyme activity found in the patient. Moreover, attention is paid to relevant items such as the occurrence of multiple and secondary defects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8444240     DOI: 10.1007/bf01956139

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  26 in total

1.  Myopathy with abnormal mitochondria, transient low electron transport capacity in the respiratory chain, and absence of energy transduction at sites 1 and 2 in vitro.

Authors:  U Trockel; H R Scholte; K V Toyka; H F Busch; I E Luyt-Houwen; J A Berden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-06       Impact factor: 10.154

2.  Carnitine deficiency, mitochondrial dysfunction and the heart. Identical defect of oxidative phosphorylation in muscle mitochondria in cardiomyopathy due to carnitine loss and in Duchenne muscular dystrophy.

Authors:  H R Scholte; R Rodrigues Pereira; H F Busch; F G Jennekens; I E Luyt-Houwen; M H Vaandrager-Verduin
Journal:  Wien Klin Wochenschr       Date:  1989-01-06       Impact factor: 1.704

3.  14CO2 production is no adequate measure of [14C]fatty acid oxidation.

Authors:  J H Veerkamp; T B van Moerkerk; J F Glatz; J G Zuurveld; A E Jacobs; A J Wagenmakers
Journal:  Biochem Med Metab Biol       Date:  1986-06

Review 4.  Methods for study of normal and abnormal skeletal muscle mitochondria.

Authors:  H S Sherratt; N J Watmough; M A Johnson; D M Turnbull
Journal:  Methods Biochem Anal       Date:  1988

Review 5.  Mitochondrial myopathies. Clinical, morphological and biochemical aspects.

Authors:  R C Sengers; A M Stadhouders; J M Trijbels
Journal:  Eur J Pediatr       Date:  1984-02       Impact factor: 3.183

6.  Combined deficiencies of the pyruvate dehydrogenase complex and enzymes of the respiratory chain in mitochondrial myopathies.

Authors:  W Sperl; W Ruitenbeek; R C Sengers; J M Trijbels; H Bentlage; J E Wraith; C Heilmann; S Stöckler; C Binder; G C Korenke
Journal:  Eur J Pediatr       Date:  1992-03       Impact factor: 3.183

7.  Defect in succinate oxidation by isolated muscle mitochondria in a patient with symmetrical lesions in the basal ganglia.

Authors:  J J Martin; F L Van de Vyver; H R Scholte; A M Roodhooft; C Ceuterick; L Martin; I E Luyt-Houwen
Journal:  J Neurol Sci       Date:  1988-04       Impact factor: 3.181

8.  Biochemical studies in the liver and muscle of patients with Zellweger syndrome.

Authors:  J M Trijbels; J A Berden; L A Monnens; J L Willems; A J Janssen; R B Schutgens; M van den Broek-Van Essen
Journal:  Pediatr Res       Date:  1983-06       Impact factor: 3.756

Review 9.  The biochemical basis of mitochondrial diseases.

Authors:  H R Scholte
Journal:  J Bioenerg Biomembr       Date:  1988-04       Impact factor: 2.945

10.  Maturation of mitochondrial and other isoenzymes of creatine kinase in skeletal muscle of preterm born infants.

Authors:  J Smeitink; W Ruitenbeek; T van Lith; R Sengers; F Trijbels; R Wevers; W Sperl; R de Graaf
Journal:  Ann Clin Biochem       Date:  1992-05       Impact factor: 2.057

View more
  9 in total

1.  [3H]dihydrorotenone binding to NADH: ubiquinone reductase (complex I) of the electron transport chain: an autoradiographic study.

Authors:  D S Higgins; J T Greenamyre
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

2.  Absence of cytochrome c oxidase activity in a boy with dysfunction of renal tubules, brain and muscle.

Authors:  A M Das; S Schweitzer-Krantz; D J Byrd; J Brodehl
Journal:  Eur J Pediatr       Date:  1994-04       Impact factor: 3.183

3.  Isolated mitochondria from frozen muscle have limited value in diagnostics.

Authors:  H R Scholte; J M Trijbels
Journal:  Eur J Pediatr       Date:  1995-01       Impact factor: 3.183

4.  Stability of frozen muscle used for mitochondrial enzyme assays.

Authors:  D A Applegarth; T Tong; L A Clarke
Journal:  Eur J Pediatr       Date:  1994-02       Impact factor: 3.183

5.  Human NADH:ubiquinone oxidoreductase.

Authors:  J Smeitink; R Sengers; F Trijbels; L van den Heuvel
Journal:  J Bioenerg Biomembr       Date:  2001-06       Impact factor: 2.945

6.  Mice lacking TR4 nuclear receptor develop mitochondrial myopathy with deficiency in complex I.

Authors:  Su Liu; Yi-Fen Lee; Samuel Chou; Hideo Uno; Gonghui Li; Paul Brookes; Michael P Massett; Qiao Wu; Lu-Min Chen; Chawnshang Chang
Journal:  Mol Endocrinol       Date:  2011-05-26

7.  A new case of multiple mitochondrial enzyme deficiencies with decreased amount of heat shock protein 60.

Authors:  P Briones; M A Vilaseca; A Ribes; A Vernet; M Lluch; V Cusi; A Huckriede; E Agsteribbe
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

Review 8.  Mitochondrial disorders: prevalence, myths and advances.

Authors:  D R Thorburn
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Human mitochondrial transmembrane metabolite carriers: tissue distribution and its implication for mitochondrial disorders.

Authors:  M Huizing; W Ruitenbeek; L P van den Heuvel; V Dolce; V Iacobazzi; J A Smeitink; F Palmieri; J M Trijbels
Journal:  J Bioenerg Biomembr       Date:  1998-06       Impact factor: 2.945

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.